Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/08/2013US8551525 Bone graft materials and methods
10/08/2013US8551516 Administration of non-oral androgenic steroids to women
10/08/2013US8551509 Skin agent for external use and cosmetic agent including ubiquinone derivative or salt thereof and method using the same
10/08/2013US8551494 Methods of immune modulation with death receptor-induced apoptosis
10/08/2013US8551493 Peptide with reduced dimer formation
10/08/2013US8551492 Vaccine peptide combinations against cat allergy
10/08/2013US8551490 Genetic products differentially expressed in tumors and use thereof
10/08/2013US8551489 Methods for the treatment of cancers
10/08/2013US8551488 Binding molecules for treatment and detection of cancer
10/08/2013US8551487 Methods for the treatment of IL-1β related conditions
10/08/2013US8551475 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
10/08/2013US8551469 Treatment of tumors and viral diseases with recombinant interferon alpha
10/08/2013US8551468 Absorption enhancers for intranasal interferon administration
10/08/2013US8551467 Replenishment and enrichment of ocular surface lubrication
10/08/2013US8551456 Combination therapy and methods for treating bacterial biofilms
10/08/2013US8551447 Bifunctional compound with monosaccharide and N2S2 ligand, and preparation and use thereof
10/08/2013CA2752943C A method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
10/08/2013CA2678575C Compounds having a cyclic moiety and compositions for delivering active agents
10/08/2013CA2673516C Method of purifying apolipoprotein a-1
10/08/2013CA2605651C Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
10/08/2013CA2570321C Inhibitors of iap
10/08/2013CA2512647C Method for manufacturing recombinant polyclonal proteins
10/08/2013CA2495048C Hemostatic compositions and devices
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/08/2013CA2453403C Methods of inhibiting amyloid toxicity
10/08/2013CA2382817C Use of fibrin or fibrinogen for reducing lung tissue volume
10/08/2013CA2380753C Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor
10/08/2013CA2349839C Ucp5
10/08/2013CA2238893C Il-13 receptor polypeptide
10/03/2013WO2013149259A1 Method for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
10/03/2013WO2013149172A1 Methods and compositions for the prevention and treatment neuropathy
10/03/2013WO2013149163A1 Use of neuregulin to treat peripheral nerve injury
10/03/2013WO2013149030A2 Use of thymosin alpha for the treatment of sepsis
10/03/2013WO2013149010A1 Enhanced antimicrobial lytic activity of a chimeric ply187 endolysin
10/03/2013WO2013148987A1 Compositions and methods for treating intestinal bacterial infections
10/03/2013WO2013148968A1 Methods for preparing dry formulations of glucose binding protein
10/03/2013WO2013148966A1 Transmucosal delivery of engineered polypeptides
10/03/2013WO2013148871A1 Engineered polypeptides
10/03/2013WO2013148689A1 Neuropeptide y treatment of autoimmune disease
10/03/2013WO2013148688A1 Pea protein containing nutritional compositions
10/03/2013WO2013148685A1 Pea protein containing nutritional compositions
10/03/2013WO2013148579A1 Pegylated c-peptide
10/03/2013WO2013148405A2 Treatment for atherosclerosis
10/03/2013WO2013148372A1 Methods for amelioration of autoimmune disease using stem cells transduced with t cell receptors from il-10 secreting t cells
10/03/2013WO2013148337A1 Methods for treating neoplasia
10/03/2013WO2013148323A1 Methods of analyzing and preparing protein compositions
10/03/2013WO2013148305A1 Method for treating diabetic retinopathy
10/03/2013WO2013148277A1 Subcutaneous administration of iduronate- 2-sulfatase
10/03/2013WO2013148248A1 Protease-regulated antibodies
10/03/2013WO2013148232A1 Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
10/03/2013WO2013148224A1 Anti-tumor properties of dickkopf 3b
10/03/2013WO2013148158A1 Laser-actuated therapeutic nanoparticles
10/03/2013WO2013148155A1 Compositions and methods for the treatment of dry eye disease
10/03/2013WO2013148117A1 Compositions and methods of use for treating metabolic disorders
10/03/2013WO2013148049A1 Recombinant cytotoxic t-lymphocyte-associated protein 4 (ctla4)
10/03/2013WO2013147899A1 Osteoprotegerin derived composition and use thereof
10/03/2013WO2013147690A1 Method for treatment of labor arrest
10/03/2013WO2013147689A1 Combination treatment comprising sulphated glycosaminoglycans for inducing labor
10/03/2013WO2013147584A1 Antiviral composition against flavivirus
10/03/2013WO2013147559A1 A liquid formulation of highly concentrated long-acting human growth hormone conjugate
10/03/2013WO2013147509A1 Epitopes of epidermal growth factor receptor surface antigen and use thereof
10/03/2013WO2013147263A1 Novel use of acetyltransferase competitive inhibitory factor gm16515
10/03/2013WO2013147125A1 Drug intake enhancer
10/03/2013WO2013147049A1 Novel artificial lipopeptide
10/03/2013WO2013145379A1 Capsule disintegrable in large-intestine-specific manner
10/03/2013WO2013144704A1 Immunomodulating cyclic compounds from the bc loop of human pd1
10/03/2013WO2013144579A1 Use of flagellin as a vaccine
10/03/2013WO2013144519A1 Food compositions for stimulating the formation of bone tissue
10/03/2013WO2013144273A1 Basal insulin therapy
10/03/2013WO2013144247A1 Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles
10/03/2013WO2013144193A1 Combination therapy for treating hcv infection in specific patient subgenotype sub-population
10/03/2013WO2013144113A1 Methods and pharmaceutical compositions for prevention or treatment of ischemia related organ damage
10/03/2013WO2013143876A1 Fviia-stf complexes exhibiting exosite-mediated super activity
10/03/2013WO2013143581A1 Combination therapy for treating hcv infection in specific patient subgenotype sub-population
10/03/2013WO2013143501A1 Hydrate of cyclopeptide compound as well as preparation method and use thereof
10/03/2013WO2013143499A1 High-purity cyclopeptide crystal as well as preparation method and use thereof
10/03/2013WO2013143497A1 High purity cyclopeptide compound as well as preparation method and use thereof
10/03/2013WO2013143021A1 Use of xanthomonas campestris effector protein as uridine monophosphate transferase
10/03/2013WO2013142982A1 Colca1 and colca2 and their use for the treatment and risk assessment of colon cancer
10/03/2013WO2013142965A1 Sh2 domain variants
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013WO2013142901A1 Silk polypeptides
10/03/2013WO2013010710A3 Surfactant hair treatment agent comprising poly-l-lysine i
10/03/2013WO2013006486A3 Compositions, uses and methods for treatment of metabolic disorders and diseases
10/03/2013US20130263296 Cancer imaging with therapy: theranostics
10/03/2013US20130261336 Methods and compositions for increasing the anaerobic working capacity in tissues
10/03/2013US20130261064 N-carboxyalkyl-auristatin and the use thereof
10/03/2013US20130261062 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders
10/03/2013US20130261059 Compositions and Methods for the Diagnosis and Treatment of Primary Insulin-Like Growth Factor Deficiency (PIGFD) and Idiopathic Short Stature (ISS)
10/03/2013US20130261058 Acceleration of wound healing by growth hormone releasing hormone and its agonists
10/03/2013US20130261057 Methods for therapeutic treatment of benign prostatic hypertrophy (bph)
10/03/2013US20130261056 Vegf antagonist formulations
10/03/2013US20130261055 Novel N- and C- terminal substituted antagonistic analogs of GH-RH
10/03/2013US20130261051 Treating Diabetes Melitus Using Insulin Injections Administered With Varying Injection Intervals
10/03/2013US20130261050 Oral combination therapy for treating hcv infection in specific patient sub-population
10/03/2013US20130261047 Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
10/03/2013US20130260453 Method for expression of small rna molecules within a cell
10/03/2013US20130259933 Capsule which disintegrates specifically in the large intestine
10/03/2013US20130259929 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
10/03/2013US20130259901 Neuropeptide Y Treatment of Autoimmune Disease
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 3163